Where can physical AI create business value?
Physical AI increases productivity, improves quality, and reduces operational delays and capacity limits. It takes over repeatable, structured tasks such as packaging changeover and visual inspection. This frees skilled staff for work that needs their expertise, such as reviewing batches before release.
What do you need before deploying physical AI?
Three foundations matter most. First, have a clear plan for proving the system meets regulatory requirements. Second, make sure your data is clean and connected. That includes data from your manufacturing execution system (MES), which tracks production on the factory floor, your warehouse management system (WMS), which tracks stock and warehouse tasks, and your sensors. Third, choose a solution that works in your existing (brownfield) facility, so you don’t have to rebuild it.
What are opportunities and hurdles?
Opportunities
- Increased operational capacity
- Improved quality and consistency
- Safer deployment through simulation
One large medical device company we work with moved from manual sample-tube handling to dark lab automation (a “lights-out” lab where robots handle routine work with little human involvement). Using 3D vision, multi-camera inspection, and robotic pick-and-place, it reduced handling errors and contamination risks by more than 50%, raised lab throughput by more than 40%, and lowered labor-related operating costs by more than 30%. Automation was deployed up to 40% faster.
Hurdles
- Proving systems can be trusted
- Ensuring reliable data
- Connecting new capabilities across existing operations
Most programs stall between pilot and production, usually because the hurdles were left until too late.
How will physical AI change life sciences over the next five years?
Physical AI will move from contained, measurable use cases into core life sciences manufacturing and supply chain operations. Autonomy will grow only as each stage produces validated results, first in simulation, then in supervised production. That moves the industry from human-in-the-loop (people approve each AI action) to human-in-command (people set objectives and oversee prompts). The evidence built on the factory floor will earn higher-stakes clinical deployments.
